Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amdipharm Mercury Company (AMCo) has launched Nicardipine injection in the UK for the treatment of acute life-threatening hypertension situations, such as encephalopathy, post operatively and eclampsia in pregnancy.
Subscribe to our email newsletter
The drug has already been used in hospitals in Europe for some time and this will be the first introduction of the injection, licensed for use in the UK.
It works by relaxing blood vessels and reduces the workload on the heart, which leads to a fall in blood pressure and also helps prevent chest pain and angina by making the heart more effective in pumping blood against less resistance.
The launch of Nicardipine 10mg/ml solution for injection took place at the British Hypertension Society’s Annual Scientific meeting in Edinburgh.
AMCo chief executive John Beighton said: "I am really pleased to be able to introduce this treatment into hospitals in the UK.
"It gives British health professionals access to the same treatment as their European colleagues when caring for patients with very high blood pressure."
Earlier this month, the company has also introduced the medicine Nebivolol into the UK and is available as a 2.5mg tablet from GPs.
The drug is used for patients suffering from high blood pressure and also for mild and moderate chronic heart failure in people aged 70 years and older.